Ochre News

NEWS COVERAGE

Ochre Bio raises $30 million for RNA-based liver disease therapies

$30 million financing for RNA therapies for chronic liver diseases

Oxford biotech raises funds to make RNA treatments for liver disease

Ochre Bio raises $30M for liver disease research

RNA therapies startup Ochre Bio lands $30M to take on chronic liver disease

A liver disease upstart with some global connections and a new R&D strategy reaps a $30M launch round

Skydivers raise almost £10,000 for children at Helen & Douglas House

A New Era in European Life Sciences Investment

Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment

Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge

‘Day job and a gay job’: LGBTQ+ leaders in biopharma want those who look, talk and love like them to be seen and counted

Biotech Startup Ochre Bio Lands Seed Financing to Combat Liver Diseases

Biotech looks to upset the preclinical model for liver drug development, and now it’s gearing up for the clinic

New hope for beating the hidden fatty liver epidemic, a silent killer

Entrepreneur First’s Latest European Cohort Revealed, With Plenty Of Biotech Startups On Show

All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits

Press Releases

October 31, 2022

October 20, 2022

October 10, 2022

August 16, 2022

April 12, 2022

December 14, 2021

Subscribe for Updates

More
Careers
News

Contact

Locations
Oxford, UK
Taipei City, Taiwan
New York, NY

Contact
contact@ochre-bio.com